eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.depression in male partner may lower pregnancy chances
.
. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
share via email email
. february 16, 2018
.
embolization “cuts off the blood supply to a certain part of the body,” according to the national institutes of health.
.
'indian ip and liabilities law barrier to pharma r&d investment'